ARBUTUS BIOPHARMA CORPORATION — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-0
Book Value Per Share
$0
Free Cash Flow Per Share
$-0
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-0
Return on Equity
-38.5%
Return on Assets
-29.6%
Return on Invested Capital
-43.9%
Debt to Equity
0.00
Current Ratio
15.73
Quick Ratio
15.73
Asset Turnover
0.12
Days Sales Outstanding
37.50
R&D / Revenue
179.2%
SBC / Revenue
49.4%
Capex / Revenue
0.0%
Working Capital
$88M
Net Current Asset Value
$76M
Invested Capital
$77M
OCF / Net Income
1.18
FCF / Net Income
1.18
Accruals Ratio (Sloan)
6.5%
Net Debt
$-91M
Net Debt / EBITDA
2.42
Interest Coverage
-393.40
Cash Coverage
-408.63
Capex Coverage
-356.32
Tangible Common Equity
$77M
TCE / Total Assets
80.9%
Goodwill / Total Assets
—
NOPAT
$-38M
Cash ROIC
-45.6%
WC / Revenue
628.1%
Capex / D&A
0.00
Reinvestment Rate
1.0%
Asset Growth vs Revenue Growth
-156.4%
Revenue 5Y CAGR
15.3%
Book Value 5Y CAGR
-5.6%
Stock Price (FY-end)
$5
Market Cap
$922M
P/S Ratio
65.44
P/B Ratio
12.04
P/TB Ratio
12.04
Enterprise Value
$830M
EV / Sales
58.95
FCF Yield
-4.3%
Shareholder Yield
-0.8%
R&D Yield
2.7%
Capex Yield
0.0%
Graham Number
—
Shares Variation (YoY)
3.2%
Beta (5Y)
0.97
Cost of Equity
9.4%
52W High
$5
52W Low
$3
Trailing Return 1Y
49.8%
Trailing Return 5Y
18.8%
F-Score (Piotroski)
3.00
Z-Score (Altman)
10.17
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.